Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovasculariza

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:jjkjlhj
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Photodynamic therapy (PDT) has been recommended as a main treatment for idiopathic choroidal neovascularization (I-CNV).But the visual results of PDT were inconsistent and variable,and PDT may bring severe damage to the retinal pigment epithelium and choriocapillaries.In recent years,intravitreal ranibizumab therapy,showing favorable visual outcomes,has developed as an advanced treatment for choroidal neovascularization (CNV).Although both methods have been reported to be effective in treating I-CNV,there is no detailed comparative report between the two methods.This study aimed to compare visual outcomes,retinal and choroidal thickness between intravitreal ranibizumab therapy and PDT in the treatment of I-CNV,and investigate the correlation of visual outcomes with retinal and choroidal thickness in each of the two groups.Methods Thirty-seven eyes of 37 patients with I-CNV were involved in this study; 19 eyes were treated with intravitreal ranibizumab therapy and 18 eyes were treated with PDT.The best corrected visual acuity (BCVA) was recorded before and at each follow-up visit after treatments (IogMAR).Enhanced-depth imaging optical coherence tomography (EDI-OCT) was used to evaluate the retinal structural changes,and to measure central retinal thickness (CRT) and central choroidal thickness (CCT).Results Mean BCVA was 0.64±0.27 in PDT group and 0.69±0.22 in ranibizumab group at baseline (P=0.55).When compared with the baseline,mean BCVA in PDT group was improved significantly at 3-month after PDT (0.41±0.16,P=0.002),then changed little (0.42±0.25 at 12-month,P=0.88).Whereas mean BCVA in Ranibizumab group was improved significantly at each follow-up visit.It improved much more obviously in the first month and then remained stable.The mean BCVA in the ranibizumab group was significantly better at each follow-up visit than that in PDT (P <0.05).When compared with the baseline,mean CRT in PDT group decreased significantly since 3-month visit,whereas mean CRT in ranibizumab group decreased significantly from 1-month visit.Mean CRT at 1-month and 3-month decreased much more in ranibizumab group than that in PDT group,almost in the same period as BCVA improving.When compared with the baseline,mean CCT did not change significantly at each follow-up visit in each group (P >0.05).The CCT difference was not statistically significant between the two groups at each same time visit (P >0.05).Mean BCVA was correlated with CRT,but was not correlated with CCT.Conclusions Both intravitreal ranibizumab therapy and PDT are effective for the treatment of I-CNV.It is obvious that ranibizumab therapy is significantly superior to PDT in improving BCVA and decreasing CRT.CRT decreases much more rapidly in ranibizumab group than in PDT group,simultaneously with visual improvement.CRT reduction has significant correlation with the visual outcomes in the recovery of I-CNV,whereas BCVA prognosis may have no correlation with CCT.CCT is not changed significantly after each of the treatments.Both PDT and ranibizumab therapy may have no significant effect on choroid.
其他文献
Background The therapeutic success of renal transplantation has been largely attributable to the development of effective and balanced immunosuppressive treatme
在小学语文教学中,教师要重视语文核心素养的培养,通过科学的方式培养学生的核心素质,以此全面提升学生的综合素质能力.
期刊
目的调查和掌握广西食品中~(226)Ra放射性本底水平并估算居民由膳食摄入所致内照射剂量。方法依据国标GB/T16145-1995《生物样品中放射性核素的γ能谱分析方法》和国标GB/T11
随着医疗卫生事业改革的深入,提高护理服务质量,通过质量控制规范门诊护理工作是护理管理的重点.本院于2007年10月份通过ISO9000质量管理体系认证,1年来我们运用质量管理原则
刘吉善医师是湖北省十堰市中医院主任医师,硕士生导师,湖北省知名中医。从事肝病研究30余载,勤求古训,潜心钻研,在各种肝病的诊治方面积累了丰富的临床经验,疗效显著,余有幸
Pd是一种值得纯化和回收的贵金属,而寻找能够定量地、选择性地和快速萃取以及反萃取容易的萃取剂实际上很困难.5,8-二乙基-7羟基-6-十二烷肟(LIX63,α-羟肟)是Pd的有效萃取剂
目的 探讨换位思考,人性化服务在门诊患者中的应用效果.方法 把换位思考的理念渗透到护患交流中的每个环节,提高护患沟通的技能,转变服务理念,增强服务意识,重塑护士新形象.